DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Talimogene laherparepvec
Talimogene laherparepvec
Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading As Active Melanoma
(T-VEC): an Intralesional Cancer Immunotherapy for Advanced Melanoma
Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients Keri A
April 29, 2015 BLA 125518 Talimogene Laherparepvec (Amgen)
Imlygic, INN-Talimogene Laherparepvec
Talimogene Laherparepvec in Addition to Pembrolizumab for Metastatic
Talimogene Laherparepvec Technical and Scientific Information on The
Talimogene Laherparepvec for the Treatment of Advanced Melanoma
Download The
Australian Public Assessment Report for Talimogene Laherparepvec
Oncolytic Viruses: Overcoming Translational Challenges
T-VEC, Formerly Oncovexgm-CSF), Which Is Being Developed by CTEP in Collaboration with Amgen
Efficacy and Safety of Talimogene Laherparepvec Versus Granulocyte
Talimogene Laherparepvec for the Treatment of Advanced Melanoma Patrick A
Talimogene Laherparepvec and Pembrolizumab in Recurrent Or
Patterns of Response with Talimogene Laherparepvec in Combination with Ipilimumab Or Ipilimumab Alone in Metastatic Unresectable Melanoma
Imlygic, Patients Should Read the Package Leaflet Or Contact Their Doctor Or Pharmacist
HSV-1 Oncolytic Viruses from Bench to Bedside: an Overview of Current Clinical Trials
Top View
Talimogene Laherparepvec Upregulates Immune-Cell
Regulators Approve the First Cancer-Killing Virus
Talimogene Laherparepvec 14 Days of a 28-Day Repeating Cycle
Talimogene Laherparepvec (Imlygic)
MASTERKEY-232 Manuscript
T-VEC, Which Was Compared Outcome of Melanoma Patients Treated with T-VEC in a with Subcutaneous Application of Human Real-Life Clinical Setting
Approved Belbuca™ (Buprenorphine) (Talimogene Laherparepvec), A
IMLYGICTM Safely and Effectively
Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy Frederick J
Talimogene Laherparepvec Combined with Anti-PD-1 Based
YOUR IMLYGIC® (Talimogene Laherparepvec; T-VEC) ACTION PLAN (To Be Filled out by a Member of Your Oncology Team)
IMLYGIC (Talimogene Laherparepvec) RATIONALE for INCLUSION IN
(T-VEC), a First-In-Class Intratumoral Oncolytic Viral Therapy Hasan Rehman, Ann W
Prescribing Information
Medication Guide IMLYGICTM (Imm-LY-Jik)
Oncolytic Viruses in Cancer Treatment: a Review
Study Protocol
Ipilimumab with Or Without Talimogene Laherparepvec in Unresected Melanoma